Success Metrics

Clinical Success Rate
85.2%

Based on 23 completed trials

Completion Rate
85%(23/27)
Active Trials
4(11%)
Results Posted
61%(14 trials)
Terminated
4(11%)

Phase Distribution

Ph phase_4
5
14%
Ph phase_1
8
22%
Ph not_applicable
3
8%
Ph phase_2
13
35%
Ph phase_3
7
19%
Ph early_phase_1
1
3%

Phase Distribution

9

Early Stage

13

Mid Stage

12

Late Stage

Phase Distribution37 total trials
Early Phase 1First-in-human
1(2.7%)
Phase 1Safety & dosage
8(21.6%)
Phase 2Efficacy & side effects
13(35.1%)
Phase 3Large-scale testing
7(18.9%)
Phase 4Post-market surveillance
5(13.5%)
N/ANon-phased studies
3(8.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.3%

23 of 29 finished

Non-Completion Rate

20.7%

6 ended early

Currently Active

4

trials recruiting

Total Trials

37

all time

Status Distribution
Active(4)
Completed(23)
Terminated(6)
Other(4)

Detailed Status

Completed23
Terminated4
unknown4
Recruiting3
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
37
Active
4
Success Rate
85.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.7%)
Phase 18 (21.6%)
Phase 213 (35.1%)
Phase 37 (18.9%)
Phase 45 (13.5%)
N/A3 (8.1%)

Trials by Status

active_not_recruiting13%
completed2362%
terminated411%
recruiting38%
withdrawn25%
unknown411%

Recent Activity

Clinical Trials (37)

Showing 20 of 37 trialsScroll for more
NCT06944145Phase 2

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

Recruiting
NCT04288427Not Applicable

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Recruiting
NCT02703220Phase 4

Sleep Apnea in Elderly

Recruiting
NCT01342367Not Applicable

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Active Not Recruiting
NCT06601205Phase 2

Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.

Completed
NCT01227993Phase 1

Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy

Completed
NCT00736645Phase 2

Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Completed
NCT02248701Phase 2

Testosterone Plus Finasteride Treatment After Spinal Cord Injury

Terminated
NCT05990400Phase 2

Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

Unknown
NCT04848181Early Phase 1

The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate

Completed
NCT02548117Phase 3

H-36731: Finasteride in Management of Elevated Red Blood Cells

Withdrawn
NCT03004469Phase 3

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

Completed
NCT02781311Phase 2

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Completed
NCT00475501Phase 2

5-Alpha Reductase and Anabolic Effects of Testosterone

Completed
NCT00021814Phase 3

Medical Therapy of Prostatic Symptoms

Completed
NCT01534351Phase 3

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Terminated
NCT00564460Phase 3

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Withdrawn
NCT01296672Phase 4

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

Completed
NCT00837252Phase 1

Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy

Completed
NCT00003323Phase 2

Hormone Therapy in Treating Patients With Prostate Cancer

Completed

Drug Details

Intervention Type
DRUG
Total Trials
37